$ 120,00
A dual-peptide GH secretagogue blend combining CJC-1295 (No DAC) and Ipamorelin — two compounds that act on independent receptor pathways (GHRH and ghrelin) to produce additive, physiologically patterned growth hormone release. A benchmark pairing for pituitary and GH-axis research. 10mg | Lyophilised | ≥99% purity | For research use only.
Manufactured with strict purity standards.
Independent lab verification on all compounds.
Consistent, reliable formulations.
Privacy-first delivery worldwide.
Designed for those who demand results.
CJC-1295 (No DAC) 5mg + Ipamorelin 5mg
This dual-peptide research blend pairs two of the most widely co-studied growth hormone secretagogues — CJC-1295 (without DAC) and Ipamorelin — in a single precision-dosed vial. Operating through complementary but distinct receptor pathways, this combination is a benchmark pairing in GH-axis research for studying amplified, physiologically patterned growth hormone release.
Blend Components
CJC-1295 (No DAC) — 5mg
A synthetic analogue of Growth Hormone Releasing Hormone (GHRH), CJC-1295 without DAC (also known as Modified GRF 1-29) stimulates the pituitary gland to release growth hormone via the GHRH receptor. Without the Drug Affinity Complex (DAC), it has a shorter, more pulsatile action profile — closely mimicking natural GHRH signalling and making it well-suited to physiological GH pulse modelling.
Ipamorelin — 5mg
A selective third-generation growth hormone secretagogue and ghrelin receptor (GHS-R1a) agonist. Ipamorelin stimulates GH release through a separate receptor pathway to CJC-1295, without significantly elevating cortisol, prolactin, or ACTH — providing a clean, selective signal for GH secretion research.
Why the Combination?
CJC-1295 (No DAC) and Ipamorelin act on two independent receptor systems — GHRH and ghrelin — that are known to have additive effects on GH release when activated simultaneously. This dual-pathway stimulation produces a stronger and more physiologically relevant GH pulse than either compound alone, making this pairing a standard reference combination in pituitary and GH-axis research.
Research Focus Areas
• Dual-pathway GH secretagogue studies (GHRH + ghrelin)
• Pulsatile GH release and IGF-1 axis modelling
• Pituitary function and somatotroph research
• GH selectivity vs. cortisol/prolactin response
• Body composition and lean tissue research models
• Bone density and connective tissue studies
• Sleep and recovery biology research
Specifications
• Total content: 10mg (CJC-1295 No DAC 5mg + Ipamorelin 5mg)
• Form: Lyophilised powder
• Purity: ≥99% — HPLC verified
• Storage: 2–8°C, away from light and moisture
———
Important Notice
This product is supplied strictly for laboratory research use only. It is not intended for human or veterinary use.
By purchasing, the buyer confirms they are a qualified professional or acting on behalf of a licensed research facility and accept full responsibility for safe handling, storage, and use in accordance with all applicable guidelines. No claims are made regarding the safety or effectiveness of this compound outside of a controlled research environment.
| 5 star | 0% | |
| 4 star | 0% | |
| 3 star | 0% | |
| 2 star | 0% | |
| 1 star | 0% |
Sorry, no reviews match your current selections
Manufactured with strict purity standards.
Independent lab verification on all compounds.
Consistent, reliable formulations.
Privacy-first delivery worldwide.
Designed for those who demand results.